Lenters Lindsey M, Das Jai K, Bhutta Zulfiqar A
BMC Public Health. 2013;13 Suppl 3(Suppl 3):S28. doi: 10.1186/1471-2458-13-S3-S28. Epub 2013 Sep 17.
Diarrhea is one of the major causes of death in children under five years of age, disproportionately affecting children in low- and middle-income countries. Treatment of diarrhea with oral rehydration solution addresses dehydration and reduces diarrhea related deaths. The World Health Organization Programme for the Control of Diarrhoeal Disease began in 1978 and while global ORS access rates have improved substantially over the past forty years, rates of ORS use have stagnated. Investigation is required to understand which interventions are effective in promoting the use of ORS, and where there are gaps in the literature.
We conducted a systematic search of peer-reviewed and grey literature and included interventions to promote the use of ORS for the treatment of acute diarrhea in children under 6 years. We used a standardized grading format based on the Child Health Epidemiology Research Group guidelines and performed meta-analysis for all categories with more than one data point.
We identified 19 studies for abstraction. For co-promotion of zinc and ORS, mothers in the intervention group were 1.82 (95% CI 1.17, 2.85) times more likely to use ORS to treat their child's diarrhea episode than mothers in the comparison group. Meta-analysis of ORS social marketing and mass media strategies indicates that mothers exposed to messages were 2.05 (95% CI, 0.78, 5.42) times more likely to use ORS to treat their child's diarrhea episode than unexposed mothers. However, this is not statistically significant. Both meta-analysis had significant heterogeneity and were graded as moderate/low and low quality, respectively.
We found few studies of interventions to promote the use of ORS; many categories of interventions had only one study. While there are some promising results, this analysis reinforces the need for further investigation into approaches to increasing ORS use.
腹泻是五岁以下儿童死亡的主要原因之一,对低收入和中等收入国家儿童的影响尤为严重。口服补液盐治疗腹泻可解决脱水问题并降低腹泻相关死亡率。世界卫生组织腹泻病控制规划始于1978年,尽管在过去四十年中全球口服补液盐的可及率有了显著提高,但口服补液盐的使用率却停滞不前。需要进行调查以了解哪些干预措施能有效促进口服补液盐的使用,以及文献中存在哪些空白。
我们对同行评审文献和灰色文献进行了系统检索,纳入了促进使用口服补液盐治疗6岁以下儿童急性腹泻的干预措施。我们采用了基于儿童健康流行病学研究组指南的标准化分级格式,并对所有有多个数据点的类别进行了荟萃分析。
我们确定了19项可供提取数据的研究。对于锌和口服补液盐联合推广,干预组的母亲使用口服补液盐治疗孩子腹泻发作的可能性是对照组母亲的1.82倍(95%置信区间1.17, 2.85)。口服补液盐社会营销和大众媒体策略的荟萃分析表明,接触相关信息的母亲使用口服补液盐治疗孩子腹泻发作的可能性是未接触母亲的2.05倍(95%置信区间,0.78, 5.42)。然而,这在统计学上并不显著。两项荟萃分析均存在显著异质性,分别被评为中等/低质量和低质量。
我们发现促进口服补液盐使用的干预措施研究较少;许多类别的干预措施仅有一项研究。虽然有一些有前景的结果,但该分析强化了进一步研究增加口服补液盐使用方法的必要性。